MAP Group joins EuropaBio: supporting patient access in Europe
PRESS RELEASE
Brussels, 11 December 2024 - EuropaBio is pleased to announce that the MAP Group, a growing pan-European consultancy partnering with health technology developers to achieve successful patient access across Europe, has joined as a member.
The MAP Group offers integrated consultancy services across Market Access and HEOR, Regulatory Strategy and Compliance and Medical and Scientific Affairs. Through its expertise and activities, it helps biopharma companies reach the European market and, ultimately, bring innovative therapies to patients. With local expertise and a global perspective, the team expertly navigate complex market dynamics, providing tailored, intelligent solutions that navigate the complexities of regulatory pathways and optimise market entry. Their online membership platform provides uninterrupted access to experts as well as an extensive and unique database, set of tools and invaluable content, to a wide range of pharmaceutical and biotech companies across Europe.
As the group expands its expertise across Europe, it addresses the needs of both large and small innovators by contributing unique perspectives and expertise from its teams across the UK, Ireland, Benelux, and Germany.
Dr. Claire Skentelbery, Director General of EuropaBio had this to say, “MAP becoming part of EuropaBio strengthens the expertise and knowledge required to build a thriving and sustainable healthcare system in Europe, from which patients are the beneficiaries and Europe’s innovative industries can anchor and grow.”
Steve Glass, Group CEO said, “It is a pleasure to join EuropaBio. We are keen to foster collaboration and engage in meaningful dialogue with fellow members and other European stakeholders, by representing the unique views of our diverse client base. As our footprint across geographies increases, we are looking forward to working closely with EuropaBio in our shared drive to champion a healthy Biotech sector and access for patients in Europe.”
For more information about the MAP Group visit www.mappatientaccess.com